Expess Scripts completed its $29.1 billion acquisition of Medco after the FTC determined that the combination of the two largest pharmacy-benefits management companies in the U.S. wouldn't stunt competition in the sector.
You are receiving this email because you subscribed to this feed at blogtrottr.com.